Huang S K, Liu X Q, Gong L, Yang J Y
China Pharmaceutical University, Nanjing.
Yao Xue Xue Bao. 1990;25(8):578-83.
The pharmacokinetic and pharmacodynamic profiles of N-acetyl procainamide were analyzed by integrated PK-PD model following intravenous infusion to rabbits. No significant differences between the PK parameters estimated from iv administration and intravenous infusion were found. However, two of the PD parameters were shown to be significantly different. The values of Emax, Keo, S, EC50 were found to be 120 +/- 13.2 ms, 0.0182 +/- 0.007 min-1, 2.26 +/- 0.93, 6.31 +/- 0.71 microgram/ml respectively following intravenous infusion; the corresponding values following iv administration were 53.6 +/- 2.5 ms, 0.061 +/- 0.017 min-1, 2.19 +/- 0.39, 6.21 +/- 1.74 micrograms/ml respectively.
通过向兔子静脉输注后采用整合的药代动力学-药效学模型分析了N-乙酰普鲁卡因胺的药代动力学和药效学特征。静脉注射给药和静脉输注所估算的药代动力学参数之间未发现显著差异。然而,有两个药效学参数显示存在显著差异。静脉输注后发现Emax、Keo、S、EC50的值分别为120±13.2毫秒、0.0182±0.007分钟-1、2.26±0.93、6.31±0.71微克/毫升;静脉注射给药后的相应值分别为53.6±2.5毫秒、0.061±0.017分钟-1、2.19±0.39、6.21±1.74微克/毫升。